Navigation Links
FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes
Date:10/29/2008

in children, with approximately 176,500 people under 20 years of age affected by the disease. Approximately one out of every 400 to 600 American children and adolescents has type 1 diabetes.

About Apidra(R)

Apidra(R) is a rapid-acting insulin that can be administered using an insulin infusion pump, vial and syringe, the OptiClik(R) reusable insulin pen, or intravenously under proper medical supervision in a clinical setting. Apidra(R) works fast and offers flexible insulin dosing to help manage mealtime blood sugar levels. It should be administered within 15 minutes before or within 20 minutes after the start of a meal. Along with exercise, a basal insulin, and a proper meal plan, Apidra(R) is proven to help reduce A1C levels in adults and children (4 years and older) with type 1 diabetes and adults with type 2 diabetes.

Apidra(R) is from the maker of Lantus(R) (insulin glargine [rDNA origin] injection), the number one prescribed insulin.*

About Lantus(R)

Lantus(R) is indicated for the treatment of adult and pediatric patients 6 years and older with type 1 diabetes, or adult patients with type 2 diabetes who require basal (long-acting) insulin for the control of hyperglycemia. Lantus(R) is the only 24-hour insulin approved exclusively for use once a day. Most insulins have a "peak of action," which refers to the time at which insulin reaches its maximum effect in the body. With Lantus(R), the insulin is released into the bloodstream at a relatively constant rate throughout the day and night; therefore it has no pronounced peak.

IMPORTANT SAFETY INFORMATION FOR APIDRA(R)

Apidra(R) is for adults and children (4 years and older) with type 1 diabetes and adults with type 2 diabetes for the control of high blood sugar. Apidra(R) should normally be used with a longer-acting insulin. Do not use Apidra(R) during a low blood sugar reaction (hypoglycemia) or if you are allergic to insulin glulisine.

Apidra(R) differs fro
'/>"/>

SOURCE Sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Z-Medica, a leading developer and marketer of ... line of products designed to meet the unique needs ... EMS 4x4 Dressing, QuikClot ® EMS TraumaPad ... all custom-designed to help responders stop bleeding fast and ... a hospital or trauma center. The line includes products ...
(Date:5/22/2013)... , May 22, 2013 MEDIFIRST SOLUTIONS, ... to update shareholders about some recent company developments. As ... its avenues of communication with shareholders. Integrating social media ... a Facebook page and will post updates on Twitter.  ... hashtag is #medifirstusa. Says CEO ...
(Date:5/22/2013)... , May 22, 2013  Flagship Ventures, a ... on healthcare and sustainability, today announced the appointment ... a Senior Partner. In this role, Mr. Bancel ... companies. In addition to working closely ... also serves as President and Chief Executive Officer ...
Breaking Medicine Technology:Z-Medica Launches New Line of Hemostatic Agents for use in Emergency Medical Services 2Medifirst Solutions, Inc. Announces Update To Shareholders 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 3
... Nov. 18 Starpharma Holdings Limited (ASX: SPL; OTCQX: ... of A$15.6 million through a private placement to institutional ... approximately A$24 million. , The lead investor in the ... highly regarded institutional fund manager. As a result ...
... , SAN DIEGO, Nov. 18 Rules-Based Medicine, Inc. ... and services agreement with Covance Inc. (NYSE: CVD ... powerful combination of biomarker technologies and services for use in ... RBM as its exclusive third-party provider of multiplexed protein biomarker ...
Cached Medicine Technology:Starpharma Announces $15.6 million Capital Raising 2Starpharma Announces $15.6 million Capital Raising 3Rules-Based Medicine Forms Biomarker Alliance With Covance Inc. 2Rules-Based Medicine Forms Biomarker Alliance With Covance Inc. 3
(Date:5/22/2013)... Illinois researcher says that the cornerstone of our efforts ... people to participate in the Supplemental Nutrition Assistance Program ... SNAP, formerly known as the Food Stamp Program, is ... additional improvements could be even more successful at reducing ... of I professor of agricultural and consumer economics and ...
(Date:5/22/2013)... of up to 1,000 mg per day can help ... author was Lisa Langsetmo, a Ph.D. Research Associate at ... Goltzman, Division of Endocrinology and Metabolism in the Department ... in the Musculoskeletal Disorders axis at the Research Institute ... published in the Journal of Clinical Endocrinology & ...
(Date:5/22/2013)... parents are married are less likely to be obese, ... University of Houston. , "Childhood obesity is a significant ... of all U.S. children ages 2-17 overweight or obese," ... at Rice and director of Rice,s Kinder Institute Urban ... conducted to explore the impact of family structure on ...
(Date:5/22/2013)... 22, 2012 (Hackensack, NJ) John Theurer Cancer Center at ... 50 cancer centers, will bring together leading cancer experts, ... implications of cell therapy and interventional immunology in oncology, ... , "I,m excited to bring together some of the ... and implications of cell therapies in oncology, both in ...
(Date:5/22/2013)... Garcinia cambogia select is a dual action fat ... extra fat being stored in the body. For a rapid ... fat burner helps people in this regard by making the ... it does this by secreting a hormone serotonin which makes ... from emotional overeating. In this way, it keeps a control ...
Breaking Medicine News(10 mins):Health News:Alleviating hunger in the US -- researcher says, it's a SNAP 2Health News:Alleviating hunger in the US -- researcher says, it's a SNAP 3Health News:Calcium supplements linked to longer lifespans in women 2Health News:Children of married parents less likely to be obese 2Health News:Children of married parents less likely to be obese 3Health News:Progress after recent breakthrough which opened new chapter in anti-cancer cell therapies 2Health News:Garcinia Cambogia Reviews Released Online for Fast Weight Loss Solution with Offer of Extra 3 Month Supply 2
... A researcher at Tulane University, Marie Krousel-Wood says people ... taking blood pressure medications than others. And people who ... report less intake of BP drugs. ,‘Nationally ... high blood pressure have the condition under control. Poor ...
... quota in Central educational institutions, Union Health Minister Ambumani ... media creation // and that the government's decision ... resistance was all by the media,' Ramadoss told newspersons ... the government proposal, he said 'This is in accordance ...
... cases of jaundice were detected here today even as ... to be suffering from the disease. // ... Nagar found four persons including two children were suffering ... the civil surgeon visited the area as doctors collected ...
... time women will have a vaccine to protect themselves from ... of 'Gardasil' produced by American pharmaceutical giant Merck. // ... of the vaccine, Gardasil, for use in girls and women ... allows an early release of products with potential to provide ...
... Recent research has revealed that taking antibiotics for three days ... is equally effective in the treatment of common pneumonia // ... to curb the rising problem of antibiotic-resistant bacteria, ... diseases at the Academic Medical Center, in Amsterdam said,’The question ...
... state and federal, experts warn that many million dollars ... // . ,A psychiatrist, Ian Hickie says ... were having clash in setting policies. ,The ... due to lack of clear accountability, federal-state role in ...
Cached Medicine News:Health News:Pneumonia Effectively Treated with Short-Term Antibiotic Course 2
... IM3300 EDTV Autoclavable 3CCD Video System, our newly ... truly innovative design features. Operation of the LS7500 ... to operate. To improve the safety of the ... which allows an extra layer of control before ...
Ambion's barrier tips prevent cross-contamination of samples by means of an aerosol filter. They are RNase- and DNase-free and are ideal for handling RNA, PCR applications, and for working with radio...
1000 L, Bulk Recommended for 500 and 1000 L pipettes...
Conducting disposable filter-tips....
Medicine Products: